Serum tumor necrosis factor-α level and uterine artery Doppler indices at 11-13 weeks' gestation for preeclampsia screening in low-risk pregnancies: A prospective observational study

Journal of Reproductive Immunology

Volumn 109, Issue , 2015, Pages 31-35

  Gomaa, Mostafa Fouad ^a   Naguib, Ahmed Hamdy ^a   Swedan, Khaled Hassan ^a   Abdellatif, Samia Salah ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Preeclampsia; TNF; Uterine artery Doppler

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIOGRAPHY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; LOW RISK POPULATION; OBSERVATIONAL STUDY; PREDICTION; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ULTRASOUND SCANNER; UTERINE ARTERY; BLOOD; CLINICAL TRIAL; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; PREGNANCY; RISK FACTOR;

ADULT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE ARTERY;

EID: 84928754916     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2015.02.007     Document Type: Article

References (20)

1. Carbillon L. First trimester uterine artery Doppler for the prediction of pre-eclampsia and fetal growth restriction. Matern. Fetal Neonatal Med. 2012, 25(7):877-883.
2. Dekker G., Sibai B. Early detection of pre-eclampsia. Am. J. Obstet. Gynecol. 1991, 165:160-175.
3. Edkker G. The partner's role in the etiology of pre-eclampsia. J. Obstet. Gynecol. 2003, 57:203-215.
4. Gomez O., Martinez J., Figueras F., et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet. Gynecol. 2005, 26:490-494.
5. Granger J., Alexander B., Linas M., et al. Pathophysiology of hypertension during pre-eclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001, 38(Pt. 2):718-722.
6. Hamai Y., Fuju T., Yamashitat, et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of pre-eclampsia. Am. J. Reprod. Immunol. 1997, 88:89-93.
7. Johnson M., Anim Nyame N., Johnson P., et al. Does endothelial cell activation occur with intrauterine growth restriction?. BJOG 2002, 109:836-839.
8. Jose C., Marilza V., Maria T. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am. J. Reprod. Immunol. 2007, 57:177-185.
9. Kumar A., Nargis B., Sudha P., Sarita A., Shashi S. IL-10, TNF α and IFN γ: potential early biomarkers for pre-eclampsia. Cell. Immunol. 2013, 283:70-74.
10. Martin A., Bindra R., Curicio P., et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet. Gynecol. 2001, 8:583-586.
11. Michael C., Catalin S., Guomao Z., et al. Fractional excretion of tumor necrosis factor-α in women with severe pre-eclampsia. Obstet. Gynecol. 2008, 112(1):93-100.
12. National High Blood Pressure Education Programme Working Group on High Blood Pressure in Pregnancy Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000, 183:S1-S22.
13. Nelson D., Ziadie M., Mcintire D., Rogers B., Leveno K. Placental pathology suggesting that pre-eclampsia is more than one disease. Am. J. Obstet. Gynecol. 2014, 210:66.e1-66.e7.
14. Pijnenborg R., Mclaughlin P.J., Vercruysse L., et al. Immunolocalization of TNF alpha in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998, 19:231-239.
15. Plasencia W., Maz N., Bonino S., et al. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet. Gynecol. 2007, 30:742-749.
16. Quinn M. Pre-eclampsia: 2 placental phenotypes, 1 etiology?. Am. J. Obstet. Gynecol. 2014, 211(3):313-314.
17. Serin I., O.Z.C-elik B., Basbug M., et al. Predictive value of tumor necrosis factor-alpha (TNF-α) in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002, 100(20):841-845.
18. Schipper E., Bolte A., Schalkuij K.C., et al. TNF receptor levels in pre-eclampsia - results of a longitudinal study in high risk women. J. Matern. Fetal Neonatal Med. 2005, 18:283-287.
19. World Health Organization (WHO) Make Every Mother and Child Count. World Health Report 2005, WHO, Geneva.
20. Yui J., Garcia-Lloret M., Wegmann T.G., et al. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994, 15:819-835.